Aurobindo Pharma’s arm enters into Licence agreement with Hilleman Laboratories Singapore

28 Sep 2023 Evaluate

Aurobindo Pharma’s wholly owned subsidiary -- Auro Vaccines has entered into a Licence agreement with Hilleman Laboratories Singapore Pte. to develop, manufacture and commercialize a pentavalent vaccine candidate used in children vaccination. Auro Vaccines will make milestone payments to Hilleman upon achieving certain development and clinical study outcomes. Hilleman will also be paid royalties upon commercialization of the vaccine candidate.

Aurobindo Pharma is engaged in manufacturing pharmaceutical products. It offers active pharmaceutical ingredients, intermediates and generic formulations like astemizole, domeperidone and omeprazole; anti-infective, oral and sterile antibiotics, pain management and osteoporosis segments.

Aurobindo Pharma Share Price

1188.55 -23.75 (-1.96%)
01-Feb-2026 13:26 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1617.70
Dr. Reddys Lab 1214.65
Cipla 1316.50
Zydus Lifesciences 884.00
Lupin 2119.75
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×